 |
Lisa Stalheim Pharmacology 31--331 Lineberger Cancer Center, CB# 7365 Lab Phone: 843-3256 Lab Fax: |
|
| |
||
1st Year IVB Trainee
2nd Year Graduate Student
|
||
Ph.D. Project Description:
|
Determining the role of Osmosensing Scaffold for MEKK3 (OSM) signaling in cerebral cavernous malformation pathogenesis | |
Principle Investigator: |
Dr. Gary Johnson | |
IVB Collaborator: |
||
Project Description: |
||
Rotations: |
Dr. Ken Harden: Mutational delineation of the interface involved in Rac-promoted activation of PLC- | |
| Dr. Gary Johnson: Creation and characterization of Junporter, a FRET biosensor for JNK signaling | ||
| Dr. Joann Trejo:The role of the protease activated receptor 2 (PAR2) cytoplasmic tail | ||
Familiar Techniques: |
Western blotting, immunoprecipitation, immunofluorescence, fluorescence resonance energy transfer (FRET), mouse embryonic fibroblast isolation, mouse bone marrow macrophage isolation | |
Other Techniques used in Laboratory: |
RNAi, Kinase assay, ELISA | |
Undergraduate degree: |
B.S. in Pharmaceutical Science (2003) from Drake University, Des Moines, Iowa | |
Other Professional/
Graduate degree(s): |
||
Awards/ Scholarships/ Grants/ Fellowships: |
||
Publications: |
Stalheim L, Ding Y, Gullapalli A, Paing MM, Wolfe BL, Morris DR, Trejo J. Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking. Molecular Pharmacology. 2005 Jan; 67 (1):78-87. | |
Personal Comments: |
||